| AI | activity index |
| ALCAM | activated leukocyte cell adhesion molecule |
| Anti-dsDNA | anti-double-stranded deoxyribonucleic acid |
| ACR | American College of Rheumatology |
| AUC | area under the curve |
| BAFF | B cell activating factor |
| BILAG | British Isles Lupus Assessment Group |
| BLyS | B lymphocyte stimulator |
| CD163 | cluster of differentiation 163 |
| CRR | complete renal response |
| CXCL | C-X-C motif ligand |
| DORIS | definitions of remission in SLE |
| DNA | deoxyribonucleic acid |
| eGFR | estimated glomerular filtration rate |
| ESKD | end-stage kidney disease |
| EULAR | European League Against Rheumatism |
| HR | hazard ratio |
| HMGB1+ | high mobility group box 1 |
| IL | interleukin |
| IP-10 | interferon-γ inducible protein-10 |
| KDIGO | kidney disease improving global outcomes |
| LN | lupus nephritis |
| MCP-1 | monocyte chemoattractant protein-1 |
| miRNAs | micro ribonucleic acids |
| MPs | microparticles |
| NGAL | neutrophil gelatinase-associated lipocalin |
| NK | natural killer |
| NPV | negative predictive values |
| OR | odds ratio |
| PCR | protein-creatinine ratio |
| PERR | primary efficacy renal response |
| PPV | positive predictive value |
| RNA | ribonucleic acid |
| ROC | receiver operating characteristic |
| SLE | systemic lupus erythematosus |
| SLEDAI | SLE disease activity index |
| SLE-ELISpot | anti-dsDNA autoantibodies secreting cells enzyme-linked immune sorbent spot |
| Sn | sensitivity |
| Sp | specificity |
| TWEAK | tumor necrosis factor-like weak inducer of apoptosis |
| VCAM-1 | vascular cell adhesion molecule-1 |